Incoming leader outlines innovation and growth priorities in first-day remarks
Aug 1, 2025 — CEOTimes.com
Dentsply Sirona, a global leader in dental technologies and solutions, has officially appointed Daniel Scavilla as its new President and CEO, effective August 1, 2025. Scavilla assumes the role following the planned departure of Simon Campion, who led the company through recent transformation efforts and early restructuring.
Scavilla’s arrival is seen as a strategic turning point, ushering in a new phase of innovation-led growth and operational discipline. With a proven record in medtech leadership, his appointment reflects Dentsply Sirona’s intent to capitalize on long-term industry tailwinds.
Strategic Credentials for a Shifting Industry
Scavilla brings over three decades of executive experience across medical devices and pharmaceutical sectors. Most recently, he served as CEO of Globus Medical, where he oversaw the high-profile acquisition of NuVasive and managed complex integration efforts.
Prior to Globus, he held senior roles at Johnson & Johnson and Merck, building a reputation for:
-
Leading cross-functional transformations
-
Driving growth through product innovation and commercial strategy
-
Building integrated teams across sales, R&D, and operations
In his first remarks as CEO, Scavilla emphasized a mission-driven strategy. “Dentsply Sirona is uniquely positioned at the intersection of healthcare and technology,” he said. “We’ll invest in what sets us apart—innovative products, customer trust, and a deep commitment to clinical excellence.”
Q2 Performance Sets the Stage
Scavilla’s appointment coincided with preliminary Q2 2025 earnings, offering a snapshot of current momentum. Highlights included:
-
Net sales between $930–$940 million
-
Adjusted earnings per share (EPS) between $0.50 and $0.52
-
Continued progress toward cost-efficiency goals
The company reaffirmed its full-year 2025 guidance, signaling confidence in stability during the leadership transition. Final Q2 earnings will be released August 7, with Scavilla set to lead the call.
Analysts have noted that while the company has stabilized after previous challenges, sustained value creation will require:
-
Accelerating R&D to match new market entrants
-
Expanding into digitally enabled oral health solutions
-
Navigating regulatory shifts, particularly in international markets
Leadership Vision: Focused, Integrated, Innovative
In outlining his priorities, Scavilla named three immediate focus areas:
-
Customer-Centric Product Development: Streamlining the innovation pipeline and expanding digital imaging, CAD/CAM systems, and AI-supported diagnostics.
-
Operational Excellence: Lean execution across sourcing, manufacturing, and logistics—particularly critical amid global supply constraints.
-
Organizational Alignment: Breaking down silos to foster faster decision-making and better field engagement.
“We need to be faster and more connected,” Scavilla said. “The dental profession is evolving—and so must we.”
Notably, Dentsply Sirona has been investing in dental education and partnerships with universities and DSOs (dental service organizations) to foster long-term professional loyalty.
Rebuilding Market Confidence
The leadership change comes as Dentsply Sirona continues to rebuild trust with investors following earlier financial restatements and executive turnover. The board emphasized Scavilla’s integrity and operational rigor as key to ensuring stability and future growth.
“We’re entering a new chapter where discipline, innovation, and customer relationships will drive shareholder value,” said board chair Eric Brandt.
Wall Street responded positively to the transition, with shares closing up 2.8% on August 1 following the announcement.
Outlook: Growth with Precision
Scavilla’s appointment represents more than a typical CEO transition—it’s a strategic realignment aimed at reclaiming leadership in a competitive medtech market. His track record of integration and product-led expansion positions Dentsply Sirona to meet the evolving needs of providers and patients alike.
As Scavilla put it: “We’re going to lead—not just follow—by delivering solutions that elevate the standard of care across dentistry.”
Read also: Leadership Moves Spark Growth: Mobi.AI and Converse Name New CEOs amid Strategic Expansion
